Resverlogix Conference Call & Webcast Announcement - WTRF 7 News Sports Weather - Wheeling Steubenville

Resverlogix Conference Call & Webcast Announcement

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact

SOURCE Resverlogix Corp.

TSX Exchange Symbol: RVX

CALGARY, Feb. 6, 2014 /PRNewswire/ - Resverlogix Corp. (TSX:RVX) will be hosting a conference call and webcast on Thursday, February 13, 2014 at 11 am MDT / 1 pm ET. The call will update the market on current clinical and business structure options.

Details for the conference call and webcast are as follows:

Link to webcast:

Dial in numbers:
Canada & USA Toll Free Dial In: 1-800-319-4610
Outside of Canada & USA call: +1-604-638-5340  

About Resverlogix

Resverlogix Corp. (TSX:RVX) is a clinical stage biotechnology company developing compounds involving ApoA-I production. RVX-208 is a first-in-class small molecule in development for the treatment of diseases such as atherosclerosis, Diabetes Mellitus and Alzheimer's disease. RVX-208 is the first BET bromodomain inhibitor in clinical trials. Resverlogix's common shares trade on the Toronto Stock Exchange (TSX: RVX). For further information please visit We can be followed on our blog at and our IR App found on Apple products iTunes and Android users (Google Play).

Company Contacts:        
Donald J. McCaffrey   
President and CEO    
Resverlogix Corp.   
Phone: 403-254-9252   
      Kenneth Lebioda   
SVP Business & Corporate Development
Resverlogix Corp.
Phone: 403-254-9252


©2012 PR Newswire. All Rights Reserved.